PubMed Health⌕ Search

PubMed · 12820671

Development of a framework for knowledge translation: understanding user context.

Abstract

OBJECTIVE: To develop a framework that researchers and other knowledge disseminators who are embarking on knowledge translation can use to increase their familiarity with the intended user groups. METHODS: The framework was derived from a review and analysis of the knowledge translation literature and from the authors' own experience with a variety of user groups. RESULTS: The framework consists of five domains: the user group, the issue, the research, the knowledge translation relationship, and dissemination strategies. Within each domain, the framework includes a series of questions. The questions provide the researcher with a way of organizing what he or she already knows about the user group and the knowledge translation project, of identifying what still is unknown, and of flagging what is important to learn. CONCLUSIONS: Most researchers wishing to engage in knowledge translation are moving out of their own familiar contexts. By using this framework, researchers will learn about the new contexts in which they find themselves. The insights they gain will increase their familiarity with the user group, thus aiding in the implicit goal of the interactive model of knowledge translation: making the researcher a part of the user group context.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Nora Jacobson, Dale Butterill, Paula Goering. 2003. Development of a framework for knowledge translation: understanding user context.. https://doi.org/10.1258/135581903321466067

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy].

The defining clinical features of acute and transient psychotic disorders (ICD-10: F23) are an acute onset and a duration of psychotic symptoms not exceeding 1-3 months. Previous empirical investigations show that patients with this diagnosis have a favourable prognosis, but also a high risk of relapses (58-77%). The diagnostic stability in the further course of illness seems to be low (34-73%) with a frequent diagnostic change to schizophrenia and affective disorders being observed. As yet, data from controlled clinical trials regarding therapy do not exist. The implications for the treatment of acute and transient psychotic disorders are discussed with this background.

Evidence-Based Medicine↗